Donald Hooker
Stock Analyst at Keybanc
(2.53)
# 2,291
Out of 4,944 analysts
82
Total ratings
55.95%
Success rate
9.22%
Average return
Main Sectors:
Stocks Rated by Donald Hooker
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TDOC Teladoc Health | Maintains: Overweight | $180 → $100 | $6.87 | +1,355.60% | 18 | Feb 23, 2022 | |
| CRL Charles River Laboratories International | Maintains: Overweight | $450 → $390 | $152.75 | +155.32% | 5 | Feb 17, 2022 | |
| DGX Quest Diagnostics | Maintains: Overweight | $168 → $170 | $178.68 | -4.86% | 4 | Dec 13, 2021 | |
| IQV IQVIA Holdings | Maintains: Overweight | $270 → $290 | $185.91 | +55.99% | 4 | Nov 17, 2021 | |
| PHR Phreesia | Maintains: Overweight | $70 → $73 | $27.85 | +162.12% | 8 | Jul 12, 2021 | |
| RXRX Recursion Pharmaceuticals | Initiates: Overweight | $36 | $5.41 | +565.43% | 1 | May 11, 2021 | |
| AMWL American Well | Initiates: Sector Weight | n/a | $7.06 | - | 1 | Apr 16, 2021 | |
| VEEV Veeva Systems | Maintains: Overweight | $332 → $353 | $275.43 | +28.16% | 2 | Feb 17, 2021 | |
| HQY HealthEquity | Downgrades: Sector Weight | n/a | $92.98 | - | 11 | Dec 2, 2020 | |
| MMS Maximus | Maintains: Overweight | $80 → $84 | $82.86 | +1.38% | 2 | Aug 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $8.80 | - | 8 | Jul 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $212 → $170 | $269.31 | -36.88% | 7 | Mar 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $169.08 | - | 6 | Sep 23, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $68 → $46 | $1.73 | +2,558.96% | 2 | Nov 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $24.02 | - | 1 | Oct 24, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $459.29 | - | 2 | Jul 10, 2017 |
Teladoc Health
Feb 23, 2022
Maintains: Overweight
Price Target: $180 → $100
Current: $6.87
Upside: +1,355.60%
Charles River Laboratories International
Feb 17, 2022
Maintains: Overweight
Price Target: $450 → $390
Current: $152.75
Upside: +155.32%
Quest Diagnostics
Dec 13, 2021
Maintains: Overweight
Price Target: $168 → $170
Current: $178.68
Upside: -4.86%
IQVIA Holdings
Nov 17, 2021
Maintains: Overweight
Price Target: $270 → $290
Current: $185.91
Upside: +55.99%
Phreesia
Jul 12, 2021
Maintains: Overweight
Price Target: $70 → $73
Current: $27.85
Upside: +162.12%
Recursion Pharmaceuticals
May 11, 2021
Initiates: Overweight
Price Target: $36
Current: $5.41
Upside: +565.43%
American Well
Apr 16, 2021
Initiates: Sector Weight
Price Target: n/a
Current: $7.06
Upside: -
Veeva Systems
Feb 17, 2021
Maintains: Overweight
Price Target: $332 → $353
Current: $275.43
Upside: +28.16%
HealthEquity
Dec 2, 2020
Downgrades: Sector Weight
Price Target: n/a
Current: $92.98
Upside: -
Maximus
Aug 7, 2020
Maintains: Overweight
Price Target: $80 → $84
Current: $82.86
Upside: +1.38%
Jul 6, 2020
Downgrades: Sector Weight
Price Target: n/a
Current: $8.80
Upside: -
Mar 30, 2020
Maintains: Overweight
Price Target: $212 → $170
Current: $269.31
Upside: -36.88%
Sep 23, 2019
Downgrades: Sector Weight
Price Target: n/a
Current: $169.08
Upside: -
Nov 13, 2017
Maintains: Overweight
Price Target: $68 → $46
Current: $1.73
Upside: +2,558.96%
Oct 24, 2017
Downgrades: Sector Weight
Price Target: n/a
Current: $24.02
Upside: -
Jul 10, 2017
Downgrades: Sector Weight
Price Target: n/a
Current: $459.29
Upside: -